CA
NZ
UK
AU
IND
US
FMR LLC and Abigail P. Johnson filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing their combined holdings in Oxford Industries Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 3,510,708.02 shares of Byrna Technologies Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing aggregate holdings of 68,966,497.27 shares of Corteva Inc. common stock, representing 10.3% of the class as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 6 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Avalo Therapeutics Inc. as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 8 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Penguin Solutions Inc. as of an October 30, 2026 triggering event.
FMR LLC and Abigail P. Johnson filed an amended Schedule 13G with the SEC on November 5, 2026, disclosing their beneficial ownership position in Natera Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 3 to a Schedule 13G with the SEC on November 5, 2026, disclosing their beneficial ownership of Class A Common Stock in Braze Inc. as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed an amended Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of approximately 10.4% of the common stock of Lovesac as of an October 30, 2026 triggering event.
FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in National Vision Holdings Inc. as of an event date of October 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 667,465 shares of Gossamer Bio Inc. common stock as of October 30, 2026.
Please wait processing your request...